Pasnani J S, Gulati O D, Hemavathi K G
Department of Pharmacology, Medical College, Baroda.
Indian J Physiol Pharmacol. 1989 Jul-Sep;33(3):146-50.
Oral treatment with indapamide was found to reduce blood pressure of hypertensive rats but not of normotensive rats. Chronic indomethacin treatment had no effect on blood pressure of untreated normotensive and hypertensive rats. Also indomethacin did not modify the antihypertensive effect of indapamide excluding the direct involvement of PGs in the antihypertensive effect of indapamide. Vascular reactivity to pressor agents NA, ADR and ANG was significantly increased after indomethacin treatment. This may be due to the blockade of the actions of PG in modifying vascular reactivity to vasoconstrictor agents or may be a direct effect of indomethacin on calcium fluxes. Indapamide reduced the reactivity to NA and ANG in the presence of indomethacin suggesting that the antihypertensive effect of indapamide may be through a decrease in reactivity to pressor agents which is independent of increase in the synthesis of vasodilator PGs.
发现用吲达帕胺进行口服治疗可降低高血压大鼠的血压,但对正常血压大鼠无效。长期使用吲哚美辛治疗对未经治疗的正常血压和高血压大鼠的血压均无影响。此外,吲哚美辛并未改变吲达帕胺的降压作用,排除了前列腺素直接参与吲达帕胺的降压作用。吲哚美辛治疗后,血管对升压药去甲肾上腺素、肾上腺素和血管紧张素的反应性显著增加。这可能是由于前列腺素在调节血管对血管收缩剂的反应性方面的作用被阻断,或者可能是吲哚美辛对钙通量的直接作用。在存在吲哚美辛的情况下,吲达帕胺降低了对去甲肾上腺素和血管紧张素的反应性,这表明吲达帕胺的降压作用可能是通过降低对升压药的反应性来实现的,这与血管舒张性前列腺素合成增加无关。